NCPA - National Center for Policy Analysis


November 2, 2005

In August 2001, President Bush limited federal spending on human embryonic stem-cell research to stem-cell line derived before that date. So far only 22 stem-cell lines qualify for federal funding and the National Institutes of Health provided only $24.3 million last year for research. According to Reason, individuals and state governments are now filling the gap.


  • California voters passed an initiative that created the California Institute of Regenerative Medicine that will fund research at $300 million annually for the next three years -- more than 12 times higher than current federal funding.
  • New Jersey has allocated $150 million to construct a new stem-cell research center and Governor Codey is asking voters to authorize $230 million to fund research.
  • Connecticut has passed legislation authorizing $100 million in spending on both adult and embryonic stem-cell research over the next 10 years.
  • Even red states like North Carolina and Texas are considering funding stem-cell research.

Private funding for academic stem-cell research is also rising, says Reason:

  • The Starr Foundation is providing $50 million over three years for human embryonic stem-cell research at three New York medical institutions.
  • In 2001, an anonymous donor gave Johns Hopkins University a $58.5 million gift to launch an Institute for Cell Engineering.
  • In 2004, a grateful patient pledged $25 million over the next ten years to finance stem-cell research at the UT Health Science Center in Houston.

Ironically, says Reason, by restricting federal funding, President Bush may have inadvertently encouraged the creation of more stem-cell lines than otherwise would have been created.

Source: Ronald Bailey, "Do We Really Need the Feds?" Reason, August 24, 2005.

For text:


Browse more articles on Tax and Spending Issues